SCHEMBL7651627

SCHEMBL7651627

CC(=O)c1ccc(NC(=O)C(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 7/20 0.76
KMT2A Q03164 9/20 0.66
MEN1 O00255 5/20 0.66
S1PR3 Q99500 1/20 0.66
SMN1; SMN2 Q16637 5/20 0.62
MAPT P10636 2/20 0.62
RAB9A P51151 2/20 0.62
NPC1 O15118 1/20 0.62
TAAR1 Q96RJ0 1/20 0.62
CYP3A4 P08684 1/20 0.61
CYP2C9 P11712 1/20 0.61
NPSR1 Q6W5P4 2/20 0.56
USP2 O75604 1/20 0.56
ESR1 P03372 1/20 0.56
NR4A1 P22736 1/20 0.56
PTK2B Q14289 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
KDM4E B2RXH2 1/20 0.55
BLM P54132 1/20 0.55
ALDH1A1 P00352 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657652 0.86 POLB (0.76) POLBKMT2AMEN1S1PR3SMN1; SMN2
SCHEMBL1383257 0.84 POLB (1.00) POLBKMT2AMEN1S1PR3SMN1; SMN2
SCHEMBL7657327 0.83 POLB (0.65) POLBKMT2AMEN1S1PR3SMN1; SMN2
SCHEMBL673385 0.82 HDAC1 (0.69) POLBKMT2AMEN1S1PR3SMN1; SMN2
SCHEMBL23715874 0.79 POLB (0.76) POLBKMT2AMEN1S1PR3SMN1; SMN2
SCHEMBL7655911 0.79 SMN1; SMN2 (0.66) POLBKMT2AMEN1S1PR3SMN1; SMN2
SCHEMBL7650752 0.79 POLB (0.60) POLBKMT2AMEN1S1PR3SMN1; SMN2
SCHEMBL27481438 0.77 MAPT (0.55) POLBKMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL14254805 0.77 ALDH1A1 (0.66) POLBKMT2AMEN1SMN1; SMN2MAPT
SCHEMBL1719786 0.77 RAB9A (1.00) POLBKMT2AMEN1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed
EP-1033366-A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists Pfizer Products Inc. (US) 2000-09-06 EP disclosed